Balancing the health benefits and environmental risks of pharmaceuticals: diclofenac as an example, Environment International, vol.85, pp.327-333, 2015. ,
From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: a review, Water Research, vol.111, pp.297-317, 2017. ,
Emerging organic contaminants in groundwater: a review of sources, fate and occurrence, Environmental Pollution, vol.163, pp.287-303, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00687127
Occurrence of PPCPs in the marine environment: a review, Environmental Science and Pollution Research, vol.23, issue.6, pp.4978-4991, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02086817
Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption, Environmental Pollution, vol.159, issue.10, pp.2929-2934, 2011. ,
Fate of diclofenac in municipal wastewater treatment plant-a review, Environment International, vol.69, pp.28-39, 2014. ,
Cometabolic biotransformation and impacts of the antiinflammatory drug diclofenac on activated sludge microbial communities, Science of e Total Environment, vol.657, pp.739-745, 2019. ,
Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies, Chemosphere, vol.73, issue.8, pp.1151-1161, 2008. ,
Removal of trace organics by MBR treatment: the role of molecular properties, Water Research, vol.45, issue.8, pp.2439-2451, 2011. ,
Toxicity mechanisms and synergies of silver nanoparticles in 2,4-dichlorophenol degradation by Phanerochaete chrysosporium, Journal of Hazardous Materials, vol.321, pp.37-46, 2017. ,
Polyvinyl alcoholimmobilized Phanerochaete chrysosporium and its application in the bioremediation of composite-polluted wastewater, Journal of Hazardous Materials, vol.289, pp.174-183, 2015. ,
Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation, Biodegradation, vol.21, issue.5, pp.681-689, 2010. ,
Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR, Journal of Hazardous Materials, vol.176, issue.1-3, pp.836-842, 2010. ,
Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi, World Journal of Microbiology and Biotechnology, vol.27, issue.8, pp.1839-1846, 2011. ,
Evaluation of diclofenac biodegradation by the ascomycete fungus Penicillium oxalicum at flask and bench bioreactor scales, Science of e Total Environment, vol.662, pp.607-614, 2019. ,
Biodegradation and biotransformation of polycyclic non-steroidal anti-inflammatory drugs, Reviews in Environmental Science and Bio/Technology, vol.14, issue.2, pp.229-239, 2015. ,
Microbial removal of the pharmaceutical compounds ibuprofen and diclofenac from wastewater, BioMed Research International, vol.2013, 2013. ,
Removal of sulfamethoxazole and trimethoprim from reclaimed water and the biodegradation mechanism, Frontiers of Environmental Science & Engineering, vol.12, issue.6, 2018. ,
Bacillus subtilis is a potential degrader of pyrene and benzo[a]pyrene, International Journal of Environmental Research and Public Health, vol.2, issue.2, pp.267-271, 2005. ,
Diclofenac and its transformation products: environmental occurrence and toxicity-a review, Environment International, vol.96, pp.127-138, 2016. ,
Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction, Chemosphere, vol.73, issue.3, pp.353-359, 2008. ,
Effects of the pharmaceuticals gemfibrozil and diclofenac on biomarker expression in the zebra mussel (Dreissena polymorpha) and their comparison with standardised toxicity tests, Chemosphere, vol.84, issue.5, pp.657-663, 2011. ,
Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal, Journal of Hazardous Materials, pp.40-47, 2012. ,
Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicology and Environmental Safety, vol.55, issue.3, pp.359-370, 2003. ,
Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid, Ecotoxicology and Environmental Safety, vol.59, issue.3, pp.309-315, 2004. ,
, Handbook of Microbiological Media, 2010.
Photocatalytic degradation of antiepileptic drug carbamazepine with bismuth oxychlorides (BiOCl and BiOCl/AgCl composite) in water: efficiency evaluation and elucidation degradation pathways, Journal of Photochemistry and Photobiology A: Chemistry, vol.328, pp.105-113, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01436760
Potential of the strain Raoultella sp. KDF8 for removal of analgesics, Folia Microbiologica, vol.63, issue.3, pp.273-282, 2017. ,
Enrichment of bacterial strains for the biodegradation of diclofenac and carbamazepine from activated sludge, International Biodeterioration & Biodegradation, vol.120, pp.135-142, 2017. ,
Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11, Ecotoxicology and Environmental Safety, vol.152, pp.104-113, 2018. ,
Metabolic and Co-metabolic transformation of diclofenac by enterobacter hormaechei D15 isolated from activated sludge, Current Microbiology, vol.74, issue.3, pp.381-388, 2017. ,
Occurrence patterns of pharmaceuticals in water and wastewater environments, Analytical and Bioanalytical Chemistry, vol.387, issue.4, pp.1225-1234, 2007. ,
Potential and limits of biodegradation processes for the removal of organic xenobiotics from wastewaters, ChemBioEng Reviews, vol.1, issue.2, pp.67-82, 2014. ,
Pharmaceuticals in the environment: biodegradation and effects on natural microbial communities. A review, Journal of Pharmaceutical and Biomedical Analysis, vol.106, pp.25-36, 2015. ,
Diclofenac biodegradation by newly isolated Klebsiella sp. KSC: microbial intermediates and ecotoxicological assessment, Journal of Environmental Chemical Engineering, vol.6, issue.2, pp.3242-3248, 2018. ,
Effluent from drug manufactures contains extremely high levels of pharmaceuticals, Journal of Hazardous Materials, vol.148, issue.3, pp.751-755, 2007. ,
Adaptation of natural microbial communities to degradation of xenobiotic compounds: effects of concentration, exposure time, inoculum, and chemical structure, Applied and Environmental Microbiology, vol.45, issue.2, pp.428-435, 1983. ,
Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme, Water Research, vol.40, issue.8, pp.1686-1696, 2006. ,
Metabolism studies of diclofenac and clofibric acid in activated sludge bioreactors using liquid chromatography with quadrupole-time-of-flight mass spectrometry, Journal of Hydrology, vol.372, issue.1-4, pp.109-117, 2009. ,
First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS, Analytical Chemistry, vol.80, issue.21, pp.8135-8145, 2008. ,
Occurrence of diclofenac and selected metabolites in sewage effluents, Science of e Total Environment, vol.405, issue.1-3, pp.310-316, 2008. ,
Elucidation of biotransformation of diclofenac and 4?hydroxydiclofenac during biological wastewater treatment, Journal of Hazardous Materials, vol.301, pp.443-452, 2016. ,
Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways, Biochemical Pharmacology, vol.58, issue.5, pp.787-796, 1999. ,
Identification and characterization of a bacterial cytochrome P450 for the metabolism of diclofenac, Applied Microbiology and Biotechnology, vol.85, issue.3, pp.625-633, 2010. ,
Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format, Analytical Chemistry, vol.81, issue.24, pp.9921-9929, 2009. ,
Effects of CYP2C9 * 3 and CYP2C9 * 13 on diclofenac metabolism and inhibition-based drug-drug interactions, Drug Metabolism and Pharmacokinetics, vol.25, issue.4, pp.343-350, 2010. ,
Assessing the ecotoxicity of pesticide transformation products, Environmental Science & Technology, vol.37, issue.20, pp.4617-4625, 2003. ,
Occurrence and ecotoxicological assessment of pharmaceuticals: is there a risk for the Mediterranean aquatic environment?, Science of e Total Environment, vol.639, pp.1334-1348, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02014313
Ecotoxicological evaluation of selected pharmaceuticals to Vibrio fischeri and Daphnia magna before and after photooxidation process, Ecotoxicology and Environmental Safety, vol.104, pp.247-253, 2014. ,
Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants, Ecotoxicology, vol.23, issue.8, pp.1517-1533, 2014. ,
Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?, Environmental Toxicology and Chemistry, vol.23, issue.5, pp.1344-1354, 2004. ,
Toxic effects of the non-steroidal anti-inflammatory drug diclofenac, Aquatic Toxicology, vol.68, issue.2, pp.141-150, 2004. ,
Assessment of diclofenac LC 50 reference values in juvenile and embryonic stages of the zebrafish (Danio rerio), Polish Journal of Veterinary Sciences, vol.14, issue.4, pp.545-549, 2011. ,
Biomarker assessment of toxicity with miniaturised bioassays: diclofenac as a case study, Ecotoxicology, vol.21, issue.1, pp.289-296, 2012. ,
Glucose repression of luminescence and luciferase in Vibrio fischeri, Archives of Microbiology, vol.134, issue.2, pp.87-91, 1983. ,
Toxicity assessment of the maize herbicides S-metolachlor, benoxacor, mesotrione and nicosulfuron, and their corresponding commercial formulations, alone and in mixtures, using the Microtox ® test, Chemosphere, vol.93, issue.10, pp.2444-2450, 2013. ,